Stocktoria

DBV Technologies S.A. DBVT

Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-03-29
Chart by TradingView
3/9
Piotroski F — financial health
-2.63
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$5.6M$4.2M$15.7M$4.8M$5.7M
Operating income-$147.1M-$116.6M-$76.4M-$96.6M-$98.6M
Net income-$146.9M-$113.9M-$72.7M-$96.3M-$97.8M
Operating cash flow-$121.2M-$104.5M-$79.7M-$55.7M-$108.2M
Free cash flow-$121.7M-$106.8M-$80.3M-$56.4M-$109.2M
Total assets$233.7M$65.7M$183.0M$246.5M$146.7M
Total liabilities$64.9M$38.3M$42.8M$52.1M$47.4M
Shareholders' equity$168.8M$27.4M$140.2M$194.5M$99.3M
Ratios
Operating margin-2609.2%-2808.7%-486.0%-1994.9%-1727.6%
Net margin-2607.3%-2744.4%-462.4%-1987.5%-1713.5%
FCF margin-2159.6%-2573.2%-510.7%-1164.7%-1912.3%
Return on assets-62.9%-173.5%-39.7%-39.1%-66.7%
Return on equity-87.1%-415.8%-51.9%-49.5%-98.5%
Debt / equity0.01×
Current ratio3.671.434.267.563.64
Revenue growth35.8%-73.6%224.7%-15.1%-49.4%

Notable holders (13F)

InvestorSharesValue
Duquesne Family Office LLC383,363$8,008

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -2.63 (distress)

  • Working capital / assets 0.663
  • Retained earnings / assets -1.682
  • EBIT / assets -0.629
  • Equity / liabilities 2.601

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001613780 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.